108 related articles for article (PubMed ID: 1940360)
21. Hormone phage: an enrichment method for variant proteins with altered binding properties.
Bass S; Greene R; Wells JA
Proteins; 1990; 8(4):309-14. PubMed ID: 1708882
[TBL] [Abstract][Full Text] [Related]
22. [Cloning of variable region genes of anti-tetanus toxoid antibody and their expression as three kinds of engineered antibodies in E. coli].
Zan H; Yeh M
Shi Yan Sheng Wu Xue Bao; 1997 Sep; 30(3):285-92. PubMed ID: 11039023
[TBL] [Abstract][Full Text] [Related]
23. [Recombinant colorimetric antibodies: genetic construction and production in E. coli].
Ducancel F; Gillet D; Ménez A; Boulain JC
C R Acad Sci III; 1992; 315(6):221-4. PubMed ID: 1334780
[TBL] [Abstract][Full Text] [Related]
24. Construction and characterization of a Fab recombinant protein for Japanese encephalitis virus neutralization.
Wu SC; Lin YJ; Chou JW; Lin CW
Vaccine; 2004 Nov; 23(2):163-71. PubMed ID: 15531033
[TBL] [Abstract][Full Text] [Related]
25. Selective phage infection mediated by epitope expression on F pilus.
Malmborg AC; Söderlind E; Frost L; Borrebaeck CA
J Mol Biol; 1997 Oct; 273(3):544-51. PubMed ID: 9356245
[TBL] [Abstract][Full Text] [Related]
26. A selection system to study protein-RNA interactions: functional display of HIV-1 Tat protein on filamentous bacteriophage M13.
Hoffmann S; Willbold D
Biochem Biophys Res Commun; 1997 Jun; 235(3):806-11. PubMed ID: 9207243
[TBL] [Abstract][Full Text] [Related]
27. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
[TBL] [Abstract][Full Text] [Related]
28. [Expression of antibody Fab against platelet IIb/IIIa in E.coli and characterization of its biological activity].
Yang YC; Lai CN; Wang Y; Shen BF; Li Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):563-7. PubMed ID: 15367348
[TBL] [Abstract][Full Text] [Related]
29. Efficient bacterial production of functional antibody fragments using a phagemid vector.
Kuba H; Furukawa A; Okajima T; Furukawa K
Protein Expr Purif; 2008 Apr; 58(2):292-300. PubMed ID: 18077183
[TBL] [Abstract][Full Text] [Related]
30. In vivo biotinylated recombinant antibodies: construction, characterization, and application of a bifunctional Fab-BCCP fusion protein produced in Escherichia coli.
Weiss E; Chatellier J; Orfanoudakis G
Protein Expr Purif; 1994 Oct; 5(5):509-17. PubMed ID: 7827508
[TBL] [Abstract][Full Text] [Related]
31. Size of the ligand complex between the N-terminal domain of the gene III coat protein and the non-infectious phage strongly influences the usefulness of in vitro selective infective phage technology.
Cèbe R; Geiser M
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):841-9. PubMed ID: 11104694
[TBL] [Abstract][Full Text] [Related]
32. A recombinant, membrane-acting immunotoxin.
Chovnick A; Schneider WP; Tso JY; Queen C; Chang CN
Cancer Res; 1991 Jan; 51(2):465-7. PubMed ID: 1898711
[TBL] [Abstract][Full Text] [Related]
33. An optimized procedure for efficient phage display of antibody fragments with a low folding efficiency.
Kuba H; Furukawa K
Protein Expr Purif; 2009 Jun; 65(2):148-53. PubMed ID: 19297692
[TBL] [Abstract][Full Text] [Related]
34. [Increase in stability of the recombinant phage M13 carrying Escherichia coli genes rpIJL by reducing expression of cloned genes].
Vudmaska MI; Zhivolup AN; Paton EB
Genetika; 1990 Mar; 26(3):557-9. PubMed ID: 2191898
[TBL] [Abstract][Full Text] [Related]
35. Phage surface presentation and secretion of antibody fragments using an adaptable phagemid vector.
Lah M; Goldstraw A; White JF; Dolezal O; Malby R; Hudson PJ
Hum Antibodies Hybridomas; 1994; 5(1-2):48-56. PubMed ID: 7858183
[TBL] [Abstract][Full Text] [Related]
36. Application of a filamentous phage pVIII fusion protein system suitable for efficient production, screening, and mutagenesis of F(ab) antibody fragments.
Huse WD; Stinchcombe TJ; Glaser SM; Starr L; MacLean M; Hellström KE; Hellström I; Yelton DE
J Immunol; 1992 Dec; 149(12):3914-20. PubMed ID: 1460282
[TBL] [Abstract][Full Text] [Related]
37. [Establishment of bacteria display technology for Fab antibody library screening].
Xu LM; Yin CK; Ren GP; Tian H; Wang XQ; Ding LJ; Li DS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1090-3. PubMed ID: 21968310
[TBL] [Abstract][Full Text] [Related]
38. Optimization and modification of anti-rhTNF-α single chain variable fragment antibody: effective in vitro affinity maturation and functional expression of chimeric Fab.
Miao X; Li A; Chen W; Qi H; Qiu Z; Zhang Y; Zhang J; Wang M
Biomed Pharmacother; 2013 Jun; 67(5):437-44. PubMed ID: 23582792
[TBL] [Abstract][Full Text] [Related]
39. Fab assembly and enrichment in a monovalent phage display system.
Garrard LJ; Yang M; O'Connell MP; Kelley RF; Henner DJ
Biotechnology (N Y); 1991 Dec; 9(12):1373-7. PubMed ID: 1369462
[TBL] [Abstract][Full Text] [Related]
40. Phage display and bacterial expression of a recombinant Fab specific for Pseudomonas aeruginosa serotype O6 lipopolysaccharide.
Tout NL; Lam JS
Clin Diagn Lab Immunol; 1997 Mar; 4(2):147-55. PubMed ID: 9067648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
